Follow
Simon Langdon
Simon Langdon
Verified email at ed.ac.uk - Homepage
Title
Cited by
Cited by
Year
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system
A Koussounadis, SP Langdon, IH Um, DJ Harrison, VA Smith
Scientific reports 5 (1), 10775, 2015
6272015
Antitumor Activity and Pharmacokinetics in Mice of 8-Carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a Novel Drug …
MFG Stevens, JA Hickman, SP Langdon, D Chubb, L Vickers, R Stone, ...
Cancer research 47 (22), 5846-5852, 1987
5361987
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...
Breast Cancer Research 15, 1-37, 2013
4982013
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma
W Sakai, EM Swisher, C Jacquemont, KV Chandramohan, FJ Couch, ...
Cancer research 69 (16), 6381-6386, 2009
3422009
Characterization and properties of nine human ovarian adenocarcinoma cell lines
SP Langdon, SS Lawrie, FG Hay, MM Hawkes, A McDonald, IP Hayward, ...
Cancer research 48 (21), 6166-6172, 1988
2981988
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
JMS Bartlett, SP Langdon, BJB Simpson, M Stewart, D Katsaros, ...
British journal of cancer 73 (3), 301-306, 1996
2641996
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
SJ Aitken, JS Thomas, SP Langdon, DJ Harrison, D Faratian
Annals of Oncology 21 (6), 1254-1261, 2010
2492010
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor–positive patients
JF Smyth, C Gourley, G Walker, MJ MacKean, A Stevenson, ...
Clinical Cancer Research 13 (12), 3617-3622, 2007
2332007
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
C Ward, SP Langdon, P Mullen, AL Harris, DJ Harrison, CT Supuran, ...
Cancer treatment reviews 39 (2), 171-179, 2013
2252013
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup
A Bowman, H Gabra, SP Langdon, A Lessells, M Stewart, A Young, ...
Clinical cancer research 8 (7), 2233-2239, 2002
2042002
Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen
AJM O’Donnell, KG Macleod, DJ Burns, JF Smyth, SP Langdon
Endocrine-related cancer 12 (4), 851-866, 2005
1982005
Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab
D Faratian, A Goltsov, G Lebedeva, A Sorokin, S Moodie, P Mullen, C Kay, ...
Cancer research 69 (16), 6713-6720, 2009
1932009
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
SL Cooke, CKY Ng, N Melnyk, MJ Garcia, T Hardcastle, J Temple, ...
Oncogene 29 (35), 4905-4913, 2010
1892010
Growth of Small Cell Lung Cancer Cells: Stimulation by Multiple Neuropeptides and Inhibition by Broad Spectrum Antagonists in Vitro and in Vivo
T Sethi, S Langdon, J Smyth, E Rozengurt
Cancer Research 52 (9_Supplement), 2737s-2742s, 1992
1851992
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models
C Xintaropoulou, C Ward, A Wise, H Marston, A Turnbull, SP Langdon
Oncotarget 6 (28), 25677, 2015
1772015
Expression of the heat shock protein HSP27 in human ovarian cancer.
SP Langdon, GJ Rabiasz, GL Hirst, RJ King, RA Hawkins, JF Smyth, ...
Clinical cancer research: an official journal of the American Association …, 1995
1711995
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer
K Macleod, P Mullen, J Sewell, G Rabiasz, S Lawrie, E Miller, JF Smyth, ...
Cancer research 65 (15), 6789-6800, 2005
1702005
Cancer cell culture
SP Langdon
Humana 5 (9), 2010
1602010
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer
HR Hendriks, HH Fiebig, R Giavazzi, SP Langdon, JM Jimeno, ...
Annals of Oncology 10 (10), 1233-1240, 1999
1451999
The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers
R Hrstka, R Nenutil, A Fourtouna, MM Maslon, C Naughton, S Langdon, ...
Oncogene 29 (34), 4838-4847, 2010
1272010
The system can't perform the operation now. Try again later.
Articles 1–20